Karyopharm Therapeutics
Jason Lowy is an accomplished professional in the hematology and oncology sectors with significant experience in territory management and account management. Currently serving as a Hematology/Oncology Territory Manager at Karyopharm Therapeutics Inc. since February 2021, Jason previously held positions as Sr Oncology Territory Manager at Daiichi Sankyo, Inc., and Oncology Territory Manager at Clovis Oncology, along with a successful tenure as an Oncology Account Specialist at Pfizer, ranking in the top 10 nationally. Jason possesses expertise in oncology product launches, market access, nurse education, and specialty pharmacy services, complemented by a robust educational background that includes an MBA from the University of Rhode Island and dual degrees in Psychology and Addiction Counseling from Keene State College.
This person is not in the org chart
This person is not in any offices
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).